1. Platt R, Wilson M, Chan KA, Benner JS, Marchibroda J, McClellan M. The new Sentinel Network: improving the evidence of medical-product safety. N Engl J Med. 2009; 361(7):645–647.
Article
2. Observational Health Data Sciences and Informatics. Analytic tools [Internet]. [place unknown]: Observational Health Data Sciences and Informatics;c2015. cited at 2015 Dec 1. Available from:
http://www.ohdsi.org/analytic-tools/.
3. Mini-Sentinel project [Internet]. [place unknown]: Mini-Sentinel Coordinating Center;c2014. cited at 2015 Dec 1. Available from:
http://www.mini-sentinel.org/.
4. Observational Medical Outcomes Partnership. OMOP Common Data Model [Internet]. [place unknown]: Observational Medical Outcomes Partnership;2013. cited at 2015 Dec 1. Available from:
http://omop.org/CDM.
5. Boyce RD, Ryan PB, Noren GN, Schuemie MJ, Reich C, Duke J, et al. Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest. Drug Saf. 2014; 37(8):557–567.
Article
6. Yoon D, Chang BC, Kang SW, Bae H, Park RW. Adoption of electronic health records in Korean tertiary teaching and general hospitals. Int J Med Inform. 2012; 81:196–203.
Article
7. Madigan D, Ryan PB, Schuemie M, Stang PE, Overhage JM, Hartzema AG, et al. Evaluating the impact of database heterogeneity on observational study results. Am J Epidemiol. 2013; 178(4):645–651.
Article
8. Dodd S. Debating the evidence: oral contraceptives containing drospirenone and risk of blood clots. Curr Drug Saf. 2011; 6(3):132–133.
Article
9. Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, et al. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association? A scientific statement from the American Heart Association. Circulation. 2012; 125(20):2520–2544.
Article
10. Brown JS, Holmes JH, Shah K, Hall K, Lazarus R, Platt R. Distributed health data networks: a practical and preferred approach to multi-institutional evaluations of comparative effectiveness, safety, and quality of care. Med Care. 2010; 48:6 Suppl. S45–S51.
11. Curtis LH, Weiner MG, Boudreau DM, Cooper WO, Daniel GW, Nair VP, et al. Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf. 2012; 21:Suppl 1. 23–31.
Article
12. Matcho A, Ryan P, Fife D, Reich C. Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug Saf. 2014; 37(11):945–959.
Article
13. Coloma PM, Schuemie MJ, Trifiro G, Gini R, Herings R, Hippisley-Cox J, et al. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf. 2011; 20(1):1–11.
Article
14. Rijnbeek PR. Converting to a common data model: what is lost in translation? Commentary on "fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model". Drug Saf. 2014; 37(11):893–896.
Article